Cantor Fitzgerald Initiates Coverage On Amgen with Overweight Rating, Announces Price Target of $405

Benzinga · 09/27 14:38
Cantor Fitzgerald analyst Olivia Brayer initiates coverage on Amgen (NASDAQ:AMGN) with a Overweight rating and announces Price Target of $405.